Literature DB >> 27503633

Prospects for Adult Stem Cells in the Treatment of Liver Diseases.

Sharmila Fagoonee1,2,3, Elvira Smeralda Famulari2,3, Lorenzo Silengo2,3, Giovanni Camussi2,4, Fiorella Altruda2,3.   

Abstract

Hepatocytes constitute the main bulk of the liver and perform several essential functions. After injury, the hepatocytes have a remarkable capacity to regenerate and restore functionality. However, in some cases, the endogenous hepatocytes cannot replicate or restore the function, and liver transplantation, which is not exempt of complications, is required. Stem cells offer in theory the possibility of generating unlimited supply of hepatocytes in vitro due to their capacity to self-renew and differentiate when given the right cues. Stem cells isolated from an array of tissues have been investigated for their capacity to differentiate into hepatocyte-like cells in vitro and are employed in rescue experiments in vivo. Adult stem cells have gained in attractiveness over embryonic stem cells for liver cell therapy due to their origin, multipotentiality, and the possibility of autologous transplantation. This review deals with the promise and limitations of adult stem cells in clinically restoring liver functionality.

Entities:  

Year:  2016        PMID: 27503633     DOI: 10.1089/scd.2016.0144

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  5 in total

Review 1.  Human Amnion Epithelial Cell Therapy for Chronic Liver Disease.

Authors:  Neil Andrewartha; George Yeoh
Journal:  Stem Cells Int       Date:  2019-08-07       Impact factor: 5.443

Review 2.  Role of inflammatory response in liver diseases: Therapeutic strategies.

Authors:  José A Del Campo; Paloma Gallego; Lourdes Grande
Journal:  World J Hepatol       Date:  2018-01-27

3.  Clinical significance and biological roles of small nucleolar RNAs in hepatocellular carcinoma.

Authors:  Dilip Baral; Long Wu; Gaurav Katwal; Xiong Yan; Yanfeng Wang; Qifa Ye
Journal:  Biomed Rep       Date:  2018-02-12

Review 4.  Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases.

Authors:  Viviana Cernigliaro; Rossella Peluso; Beatrice Zedda; Lorenzo Silengo; Emanuela Tolosano; Rinaldo Pellicano; Fiorella Altruda; Sharmila Fagoonee
Journal:  Cells       Date:  2020-02-07       Impact factor: 6.600

5.  Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice.

Authors:  Elvira Smeralda Famulari; Victor Navarro-Tableros; Maria Beatriz Herrera Sanchez; Giulia Bortolussi; Marta Gai; Laura Conti; Lorenzo Silengo; Emanuela Tolosano; Ciro Tetta; Andrés Fernando Muro; Giovanni Camussi; Sharmila Fagoonee; Fiorella Altruda
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.